<DOC>
	<DOCNO>NCT00028171</DOCNO>
	<brief_summary>Tacrolimus medication give transplant patient help prevent rejection . The purpose study see tacrolimus take day instead twice day kidney transplant patient . Transplant patient require take several medication prevent rejection treat complication transplantation . Because complicated dosing schedule , difficult patient follow medication schedule . Taking few medication less frequently may help transplant patient well manage drug therapy . Tacrolimus good absorb body take morning take evening . This suggest tacrolimus take every morning instead twice daily order produce appropriate drug exposure prevent organ rejection without increased side effect .</brief_summary>
	<brief_title>Pharmacokinetics Tacrolimus Kidney Transplant Recipients : Once Daily Versus Twice Daily Dosing</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1 ) Kidney transplant recipient ( 18 year old ) Washington University/Barnes Hospital take tacrolimusbased immunosuppression ; 2 ) Stable kidney transplant recipient ( &gt; 6 month posttransplantation , serum creatinine &lt; 2 ml/dL , history rejection ) ; 3 ) Stable immunosuppression ( therapeutic tacrolimus concentration , change tacrolimus dose within one month prior study ) ; 4 ) Subjects must agree abstain alcohol caffeine 48 hour prior pharmacokinetics study . 1 ) Pregnant woman nurse mother ; 2 ) Patients unwilling unable comply protocol ; 3 ) Significant liver impairment ( AST ALT &gt; 2 x upper limit normal , total bilirubin &gt; upper limit normal ) ; 4 ) Anemia : Hematocrit &lt; 30 % ; 5 ) Use concomitant P450 3A4/pglycoprotein inducer inhibitor ; 6 ) Current smoking ; 7 ) Patients diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
</DOC>